16 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
11 Sep 23
Regulation FD Disclosure
8:01am
development Prevent progression and complications Indication for treatment Current area of controversy Agreement that treatments are indicated Patient
8-K
EX-10.1
q737j861z1a ree
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
8-K
EX-10.3
l7d2vm
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
8-K
EX-10.4
cwbfqnk ayl2vehffca
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFA14A
zvbgf9qdztr0v 0tf3
21 Jan 22
Additional proxy soliciting materials
4:38pm
8-K/A
EX-10.3
k2rksq5z
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K/A
EX-10.2
uc2m8
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K/A
EX-2.1
8gs8aax9vjs8u1
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K/A
EX-10.4
7mtw9 0vy3t
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K/A
EX-10.1
ojqk4xz
21 Jan 22
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.3
0o1znfpgr5go 77gptgj
2 Jul 21
Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
4:22pm
S-1
EX-10.4
w0i1u b51oqnv
2 Jun 21
IPO registration
5:17pm
- Prev
- 1
- Next